Defiance in face of EMA's Indian CRO data manipulation claims
This article was originally published in SRA
Executive Summary
The European Medicines Agency's recommendation that hundreds of generic medicines whose European marketing authorizations relied on clinical studies performed by Indian contract research organization GVK Biosciences be suspended in Europe has been met with defiance by the Indian government and some of the affected generics companies.